nach oben

International Journal of Diabetes in Developing Countries

Erschienen in:

01.12.2011 | Editorial

Metabolic syndrome

verfasst von: K. M. Prasanna Kumar

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Excerpt

Metabolic syndrome (MS) is a constellation of individual risk factors of cardiovascular disease. The World Health Organization (WHO) was the first to publish an internationally accepted definition for metabolic syndrome in 1998, but the criteria that have received the most widespread acceptance and use in the United States are those established as guidelines in the ATP III (the third report of the National Cholesterol Education Program expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults). …

Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002;106:3143–420.

Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9:237–52.PubMed

Jaggers JR, Sui X, Hooker SP, et al. Metabolic syndrome and risk of cancer mortality in men. Eur J Cancer. 2009;45:1831–8.PubMedCrossRef

Misra A, Khurana L. The metabolic syndrome in south Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord. 2009;7:497–514.PubMedCrossRef

Misra A, Chowbey P, Makkar BM, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. JAPI. 2009;57:163–70.PubMed

Enas EA, Mohan V, Deepa M, Farooq S, Pazhoor S, Chennikkara H. The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease. J Cardiometab Syndr. 2007;2:267–75.PubMedCrossRef

Reddy KS, Prabhakaran D, Chaturvedi V, Jeemon P, Thankappan KR, Ramakrishnan L, Mohan BV, Pandav CS, Ahmed FU, Joshi PP, Meera R, Amin RB, Ahuja RC, Das MS, Jaison TM. Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations. Bull World Health Organ. 2006;84:461–9.PubMedCrossRef

Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol. 2004;97:257–61.PubMedCrossRef

Misra R, Misra A, Kamalamma N, Naval K, Vikram NK, Gupta S, Sharma S, Patel T, Balagopal P. Difference in prevalence of diabetes, obesity, metabolic syndrome and associated cardiovascular risk factors in a rural area of Tamil Nadu and an urban area of Delhi. Int J Diab Dev Ctries. 2011;31:82–90.CrossRef

10.

Mahadik SR, Deo SS, Mehtalia SD. Increased prevalence of metabolic syndrome in non-obese Asian Indian-an urban–rural comparison. Metab Syndr Relat Disord. 2007;5:142–52.PubMedCrossRef

11.

Kempegowda P, et al. Prevalence of Metabolic Syndrome in Rural India - A disparity in definitions. Int J Diab Dev Ctries. doi:10.1007/s13410-011-0046-y.

Titel: Metabolic syndrome
verfasst von: K. M. Prasanna Kumar
Publikationsdatum: 01.12.2011
Verlag: Springer-Verlag
Erschienen in: International Journal of Diabetes in Developing Countries / Ausgabe 4/2011
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-011-0056-9

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2011

Asymptomatic peripheral arterial disease in type 2 diabetes mellitus: prevalence patterns and risk factor associations

Intensified insulin therapy during fasting of Ramadan in type 1 diabetic patients

Pseudoainhum of toes in type 2 diabetes

Angiotensin converting enzyme (ACE) gene polymorphism increases the susceptibility of diabetic nephropathy in Western Indian Type 2 diabetic patients

Relationship between limited joint mobility syndrome and duration, metabolic control, complications of diabetes as well as effects of the syndrome on quality of life

Switching to three pre-meal injections of insulin glulisine from the basal-bolus insulin therapy improves glycemic control in a patient with type 2 diabetes who had anti-insulin antibody